Finance

Lists
Why is NYMXF up 31.25%?
Dive Deeper
NYMXF:OTCMKTS
Nymox Pharmaceutical Corp
$0.042
+31.25%
(+0.0100) 1D
Oct 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NYMXF...
Open
$0.04
High
$0.04
Low
$0.04
Mkt. cap
4.71M
Avg. vol.
8.07K
Volume
1.28K
52-wk high
$0.20
52-wk low
$0.00
EPS
-$0.04
Beta
-0.15
Shares outstanding
105.04M
No. of employees
3
Open
$0.04
High
$0.04
Low
$0.04
Mkt. cap
4.71M
Avg. vol.
8.07K
Volume
1.28K
52-wk high
$0.20
52-wk low
$0.00
EPS
-$0.04
Beta
-0.15
Shares outstanding
105.04M
No. of employees
3
News stories
From web sources and news partners
About Nymox Pharmaceutical Corp
CEO-
Employees3
Founded1989
Headquarters-
SectorBiotechnology
Websitenymox.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2015
Dec 2015
Sep 2024
Dec 2024
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
511.00K
624.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
142.00K
164.00K
Operating expense
-
-
653.00K
788.00K
Total operating expenses
-
-
653.00K
788.00K
Operating income
-
-
-653.00K
-788.00K
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-716.00K
-857.00K
EBT excluding unusual items
-
-
-716.00K
-857.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-716.00K
-857.00K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
2.00K
Interest expense
-
-
-63.00K
-86.00K
Net interest expenses
-
-
-63.00K
-84.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-652.67K
-788.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps